Medical Device and Diagnostic Industry (MD+DI)

Edwards Lifesciences Wins FDA Approval for First Tricuspid Surgical Valve Replacement

Edwards Lifesciences gains FDA approval for Triformis Resilia, the first surgical valve for tricuspid disease, potentially ...

Edwards gets FDA approval for surgical tricuspid valve

Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
Medical Design & Outsourcing

Edwards Lifesciences makes a simple change for a first-of-its-kind tricuspid valve

The Edwards Triformis Resilia is the first surgical valve designed and approved for the tricuspid position, thanks to a small change.
Business Wire

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S.
MassDevice

Edwards gets FDA nod for Triformis Resilia surgical tricuspid valve replacement

Edwards Lifesciences (NYSE:EW) said today that it received FDA approval for Triformis Resilia, its surgical tricuspid valve ...
MD&M East

Did Edwards Just Pull Off a 1st in the Mitral Valve Market?

Edwards Lifesciences has been awarded CE mark for the Sapien M3 mitral valve replacement system. The approval is for the transcatheter treatment of patients with symptomatic (moderate-to-severe or ...